Adaptive Biotechnologies (ADPT) Competitors $17.27 +0.16 (+0.94%) Closing price 04:00 PM EasternExtended Trading$17.50 +0.23 (+1.33%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ADPT vs. TWST, TXG, VCYT, VRNA, RVMD, ABVX, RNA, CYTK, MRUS, and RYTMShould you be buying Adaptive Biotechnologies stock or one of its competitors? The main competitors of Adaptive Biotechnologies include Twist Bioscience (TWST), 10x Genomics (TXG), Veracyte (VCYT), Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), Abivax (ABVX), Avidity Biosciences (RNA), Cytokinetics (CYTK), Merus (MRUS), and Rhythm Pharmaceuticals (RYTM). These companies are all part of the "medical" sector. Adaptive Biotechnologies vs. Its Competitors Twist Bioscience 10x Genomics Veracyte Verona Pharma PLC American Depositary Share Revolution Medicines Abivax Avidity Biosciences Cytokinetics Merus Rhythm Pharmaceuticals Adaptive Biotechnologies (NASDAQ:ADPT) and Twist Bioscience (NASDAQ:TWST) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability. Do insiders & institutionals hold more shares of ADPT or TWST? 99.2% of Adaptive Biotechnologies shares are held by institutional investors. 6.4% of Adaptive Biotechnologies shares are held by insiders. Comparatively, 3.0% of Twist Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has preferable earnings and valuation, ADPT or TWST? Adaptive Biotechnologies has higher earnings, but lower revenue than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Adaptive Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptive Biotechnologies$178.96M14.69-$159.49M-$0.82-21.06Twist Bioscience$312.97M5.93-$208.73M-$1.45-21.21 Do analysts recommend ADPT or TWST? Adaptive Biotechnologies presently has a consensus target price of $14.11, suggesting a potential downside of 18.29%. Twist Bioscience has a consensus target price of $48.50, suggesting a potential upside of 57.72%. Given Twist Bioscience's higher probable upside, analysts clearly believe Twist Bioscience is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adaptive Biotechnologies 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Twist Bioscience 2 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.58 Which has more volatility & risk, ADPT or TWST? Adaptive Biotechnologies has a beta of 2.06, meaning that its stock price is 106% more volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 2.38, meaning that its stock price is 138% more volatile than the S&P 500. Does the media refer more to ADPT or TWST? In the previous week, Twist Bioscience had 13 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 22 mentions for Twist Bioscience and 9 mentions for Adaptive Biotechnologies. Adaptive Biotechnologies' average media sentiment score of 0.41 beat Twist Bioscience's score of 0.31 indicating that Adaptive Biotechnologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adaptive Biotechnologies 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Twist Bioscience 7 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is ADPT or TWST more profitable? Twist Bioscience has a net margin of -23.51% compared to Adaptive Biotechnologies' net margin of -59.07%. Twist Bioscience's return on equity of -29.03% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Adaptive Biotechnologies-59.07% -60.93% -23.03% Twist Bioscience -23.51%-29.03%-21.77% SummaryTwist Bioscience beats Adaptive Biotechnologies on 8 of the 15 factors compared between the two stocks. Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADPT vs. The Competition Export to ExcelMetricAdaptive BiotechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.61B$3.38B$6.13B$10.46BDividend YieldN/A2.30%5.73%4.78%P/E RatioN/A23.0785.1527.20Price / Sales14.69451.46575.41179.83Price / CashN/A46.1137.3961.86Price / Book12.6110.5012.396.65Net Income-$159.49M-$52.47M$3.32B$276.79M7 Day Performance10.35%-1.00%-0.24%-1.51%1 Month Performance33.77%14.49%9.56%5.45%1 Year Performance259.79%13.92%71.67%36.24% Adaptive Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADPTAdaptive Biotechnologies2.7998 of 5 stars$17.27+0.9%$14.11-18.3%+244.3%$2.61B$178.96M0.00790News CoverageAnalyst ForecastTWSTTwist Bioscience3.7793 of 5 stars$30.14-3.4%$48.50+60.9%-30.8%$1.88B$312.97M-20.79990Trending NewsAnalyst RevisionTXG10x Genomics4.0587 of 5 stars$11.60+1.1%$13.65+17.7%-25.3%$1.43B$610.78M-16.571,240Trending NewsAnalyst ForecastAnalyst RevisionVCYTVeracyte3.7884 of 5 stars$34.09-2.0%$40.90+20.0%+2.1%$2.74B$445.76M103.31790News CoverageVRNAVerona Pharma PLC American Depositary Share1.4419 of 5 stars$106.91flat$109.00+2.0%N/A$9.21B$42.28M-107.9930Positive NewsRVMDRevolution Medicines4.2597 of 5 stars$48.75+1.1%$74.64+53.1%+1.2%$9.02B$11.58M-10.83250Analyst ForecastInsider TradeABVXAbivax3.4651 of 5 stars$95.63+2.0%$114.25+19.5%+908.5%$7.30BN/A0.0061Analyst ForecastShort Interest ↓Gap UpRNAAvidity Biosciences2.5737 of 5 stars$48.96-1.6%$68.32+39.5%+8.1%$7.26B$10.90M-13.75190CYTKCytokinetics3.8297 of 5 stars$59.59-0.7%$76.64+28.6%+13.4%$7.18B$18.47M-11.68250Insider TradeMRUSMerus1.5577 of 5 stars$94.85+0.5%$93.12-1.8%+84.9%$7.14B$36.13M-17.2537Short Interest ↓RYTMRhythm Pharmaceuticals3.078 of 5 stars$100.770.0%$106.64+5.8%+116.9%$6.70B$130.13M-33.48140Analyst Forecast Related Companies and Tools Related Companies Twist Bioscience Competitors 10x Genomics Competitors Veracyte Competitors Verona Pharma PLC American Depositary Share Competitors Revolution Medicines Competitors Abivax Competitors Avidity Biosciences Competitors Cytokinetics Competitors Merus Competitors Rhythm Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADPT) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersIs *BSEM* Oversold??BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The com...Huge Alerts | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredWall St’s “AI Godfather” breaks his silenceWhats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
